HSKA Share Price

Open 104.57 Change Price %
High 105.57 1 Day 0.44 0.42
Low 104.16 1 Week 3.34 3.28
Close 105.17 1 Month 6.45 6.53
Volume 64829 1 Year 76.39 265.43
52 Week High 107.18
52 Week Low 26.25
HSKA Important Levels
Resistance 2 106.48
Resistance 1 105.94
Pivot 104.97
Support 1 104.40
Support 2 103.86
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
SIRI 5.07 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
MAT 21.79 -13.57%
More..
NASDAQ USA Top Gainers Stocks
ESSX 0.22 69.23%
MYRX 0.08 60.00%
CGEI 0.35 59.09%
LOCM 0.09 50.00%
RITT 0.03 50.00%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CARV 4.90 22.81%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
ULTR 0.05 -37.50%
More..

Heska Corporation (NASDAQ: HSKA)

HSKA Technical Analysis 5
As on 21st Apr 2017 HSKA Share Price closed @ 105.17 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 63.85 & Strong Buy for SHORT-TERM with Stoploss of 93.27 we also expect STOCK to react on Following IMPORTANT LEVELS.
HSKA Target for April
1st Target up-side 114.38
2nd Target up-side 120.96
3rd Target up-side 127.55
1st Target down-side 95.58
2nd Target down-side 89
3rd Target down-side 82.41
HSKA Other Details
Segment EQ
Market Capital 44654696.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.heska.com
HSKA Address
HSKA
3760 Rocky Mountain Avenue
Loveland, CO 80538
United States
Phone: 970-493-7272
Fax: 970-619-3003
HSKA Latest News
Interactive Technical Analysis Chart Heska Corporation ( HSKA NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Heska Corporation
HSKA Business Profile
Heska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. It operates in two segments: Core Companion Animal Health and Other Vaccines, Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes diagnostic instruments and supplies, as well as single use diagnostic and other tests, vaccines and pharmaceuticals, primarily for canine and feline use. These products are sold directly by the Company as well as through independent third-party distributors and through other distribution relationships. The Other Vaccines, Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals and fish. In February 2013, it announced the acquisition of 54.6% interest of Cuattro Veterinary USA, LLC.